文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

台北市院外心脏骤停成人:声门上气道装置与气管插管对自主循环恢复的影响——一项集群随机临床试验

Effect of Placement of a Supraglottic Airway Device vs Endotracheal Intubation on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest in Taipei, Taiwan: A Cluster Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2022-02-01
一句话结论在非创伤性院外心脏骤停成人中,初始气管插管与声门上气道装置相比,持续自主循环恢复率无显著差异(26.9% vs 25.8%,OR 1.02,95%CI 0.98-1.06)。

SAVE试验为在台北市开展的多中心集群随机临床试验,纳入2016年11月11日至2019年12月31日期间由参与急救机构救治的20岁及以上非创伤性院外心脏骤停需高级气道管理患者,比较初始气管插管(ETI)与声门上气道装置(SGA)的效果。共936例患者纳入主要分析(ETI组517例,SGA组419例),主要终点持续自主循环恢复(≥2小时)在ETI组为26.9%,SGA组为25.8%,OR 1.02(95%CI 0.98-1.06)。院前自主循环恢复OR 1.04(95%CI 1.02-1.07),出院存活OR 1.00(95%CI 0.94-1.06),脑功能分类评分≤2的OR 0.99(95%CI 0.94-1.03)。结论认为初始ETI与SGA相比未带来更有利的持续自主循环恢复结局。

要点

  • 主要终点持续自主循环恢复(≥2小时):ETI组26.9%(139例) vs SGA组25.8%(108例),OR 1.02(95%CI 0.98-1.06)。
  • 院前自主循环恢复:ETI vs SGA的OR 1.04(95%CI 1.02-1.07)。
  • 出院存活:ETI vs SGA的OR 1.00(95%CI 0.94-1.06);脑功能分类评分≤2:OR 0.99(95%CI 0.94-1.03)。
  • 首次气道成功率:ETI 77%(413例) vs SGA 83%(360例)。
  • 作者结论:在院外心脏骤停患者中,初始ETI与SGA装置置入相比,未带来更有利的持续自主循环恢复结局。

适用人群与场景

  • 20岁及以上、发生非创伤性院外心脏骤停、需要高级气道管理、由参与急救机构救治的患者,纳入时间为2016年11月11日至2019年12月31日,末次随访日期为2020年2月19日。

处置流程与药物剂量

  • 4个高级生命支持救护队分为2个随机集群,每2周交替分配至ETI或SGA。

研究设计与关键结果

  • SAVE试验为在台北市开展的多中心集群随机临床试验,共936例患者纳入主要分析(ETI组517例,SGA组419例;中位年龄77岁[IQR 62-85],男性569例[60.8%]),比较初始ETI与SGA。
  • 主要终点持续自主循环恢复(≥2小时):ETI组26.9%(139例) vs SGA组25.8%(108例),OR 1.02(95%CI 0.98-1.06)。
  • 首次气道成功率:ETI 77%(413例) vs SGA 83%(360例)。
  • 院前自主循环恢复:ETI vs SGA的OR 1.04(95%CI 1.02-1.07)。
  • 出院存活:ETI vs SGA的OR 1.00(95%CI 0.94-1.06)。
  • 脑功能分类评分≤2:ETI vs SGA的OR 0.99(95%CI 0.94-1.03)。
  • 预设亚组及至高级气道时间与结局的关联进行了探索,并进行了符合方案集和意向性治疗分析。

证据类型、等级与局限

  • 证据类型:多中心集群随机临床试验(SAVE试验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在院外心脏骤停患者中,初始ETI与SGA装置置入相比,未带来更有利的持续自主循环恢复结局。

指南或共识出处

  • 试验注册:ClinicalTrials.gov Identifier: NCT02967952。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Prehospital advanced airway management with either initial endotracheal intubation (ETI) or initial supraglottic airway (SGA) insertion in patients with out-of-hospital cardiac arrest (OHCA) remains controversial.

OBJECTIVE: To compare the effectiveness of ETI and SGA in patients with nontraumatic OHCA.

DESIGN, SETTING, AND PARTICIPANTS: The Supraglottic Airway Device vs Endotracheal intubation (SAVE) trial was a multicenter cluster randomized clinical trial conducted in Taipei City, Taiwan. Individuals aged 20 years or older who experienced nontraumatic OHCA requiring advanced airway management and were treated by participating emergency medical service agencies were enrolled from November 11, 2016, to December 31, 2019. The final day of follow-up was February 19, 2020.

INTERVENTIONS: Four advanced life support ambulance teams were divided into 2 randomization clusters, with each cluster assigned to either ETI or SGA in a biweekly period.

MAIN OUTCOMES AND MEASURES: The primary outcome of the SAVE trial was sustained return of spontaneous circulation (ROSC) (≥2 hours) after resuscitation. Secondary outcomes included prehospital ROSC, survival to hospital discharge, and favorable neurologic outcome, defined as a cerebral performance category score less than or equal to 2. Prespecified subgroups and the association between time to advanced airways were explored. Per protocol and intention-to-treat analysis were performed.

RESULTS: A total of 936 patients (517 in the ETI group and 419 in the SGA group) were included in the primary analysis (median age, 77 [IQR, 62-85] years; 569 men [60.8%]). The first-attempt airway success rates were 77% with ETI (n = 413) and 83% with SGA (n = 360). Sustained ROSC was 26.9% (n = 139) in the ETI group vs 25.8% (n = 108) in the SGA group. The odds ratio of sustained ROSC was 1.02 (95% CI, 0.98-1.06) in the ETI group vs SGA group. The odds ratio of ETA vs SGA was 1.04 (95% CI, 1.02-1.07) for prehospital ROSC, 1.00 (95% CI, 0.94-1.06) for survival to hospital discharge, and 0.99 (95% CI, 0.94-1.03) for cerebral performance category scores less than or equal to 2.

CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, among patients with OHCA, initial airway management with ETI did not result in a favorable outcome of sustained ROSC compared with SGA device insertion.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02967952.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Lee AF, Chien YC, Lee BC, et al. Effect of Placement of a Supraglottic Airway Device vs Endotracheal Intubation on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest in Taipei, Taiwan: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2022. PMID: 35179588. doi:10.1001/jamanetworkopen.2021.48871

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。